Aaron Appiah, MD
Retina Specialist · Tallahassee, FLNPI 1568473619
Payments from drug & device makers
Across 62 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$565
- Sun Pharmaceutical Industries Inc.$115
- Aerie Pharmaceuticals, Inc.$103
- Kala Pharmaceuticals, Inc.$97
- Novartis$85
- Bausch & Lomb Americas Inc.$72
- plus $236 from 10 others
What the payments were for
- Food & beverage$1,22997%
- Education$242%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $565 |
| Sun Pharmaceutical Industries Inc. | 7 | $115 |
| Aerie Pharmaceuticals, Inc. | 5 | $103 |
| Kala Pharmaceuticals, Inc. | 1 | $97 |
| Novartis | 4 | $85 |
| Bausch & Lomb Americas Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $38 |
| Harrow Eye, LLC | 1 | $30 |
| Amgen | 1 | $24 |
| Alimera Sciences, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| Alcon | 1 | $14 |
How this compares
$1,273 in reported general payments places this provider in the 25th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Difluprednate | 11 | $910 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Tallahassee
- Shailesh GuptaDeerfield Beach$18.8M
- Vrinda HershbergerMelbourne$8.2M
- Sunil GuptaPensacola$8.1M
- Stuart BurgessPlantation$4.6M
- Eduardo UchiyamaFt Lauderdale$4.1M
- Drew BawcombeDeerfield Beach$2M
- Dana DeupreeSpring Hill$1.5M
- Eric GuglielmoMerritt Island$1.5M
- Jason HandzaPinellas Park$1.3M
- Ashish SharmaFort Myers$994K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.